Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 348.00 | 274.75 | 1.2666 | 1.6519 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 153.73 | 121.00 | 274.75 | 0.4404 | -0.2486 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 275.00 | 274.75 | 1.0009 | 1.0022 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 644.00 | 843.25 | 0.7637 | 0.6491 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 857.00 | 843.25 | 1.0163 | 1.0233 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 818.00 | 843.25 | 0.9701 | 0.9570 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 625.00 | 320.09 | 810.00 | 843.25 | 0.9606 | 0.9433 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 320.09 | 1003.00 | 843.25 | 1.1894 | 1.2644 |
| BT-20 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 888.00 | 843.25 | 1.0531 | 1.0754 |
| BT-20 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 320.09 | 685.00 | 843.25 | 0.8123 | 0.7236 |
| BT-20 | Lapatinib | 0.1 | uM | 9 | 625.00 | 320.09 | 965.00 | 843.25 | 1.1444 | 1.2026 |
| BT-20 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 320.09 | 1004.00 | 843.25 | 1.1906 | 1.2660 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 997.00 | 843.25 | 1.1823 | 1.2547 | |
| BT-20 | 17-AAG | 0.1 | uM | 9 | 625.00 | 320.09 | 286.00 | 843.25 | 0.3392 | -0.0774 |
| BT-20 | Erlotinib | 0.1 | uM | 9 | 625.00 | 320.09 | 1019.00 | 843.25 | 1.2084 | 1.2901 |
| BT-20 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 1046.00 | 843.25 | 1.2404 | 1.3334 |
| BT-20 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 320.09 | 1103.00 | 843.25 | 1.3080 | 1.4237 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 625.00 | 320.09 | 1032.00 | 843.25 | 1.2238 | 1.3110 |
| BT-20 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 1153.00 | 843.25 | 1.3673 | 1.5018 |
| BT-20 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 320.09 | 923.00 | 843.25 | 1.0946 | 1.1336 |
| BT-20 | Erlotinib | 1 | uM | 9 | 625.00 | 320.09 | 913.00 | 843.25 | 1.0827 | 1.1170 |
| BT-20 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 320.09 | 1012.00 | 843.25 | 1.2001 | 1.2789 |
| BT-20 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 320.09 | 685.00 | 843.25 | 0.8123 | 0.7236 |
| BT-20 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 320.09 | 223.00 | 843.25 | 0.2645 | -0.2279 |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 908.00 | 843.25 | 1.0768 | 1.1087 |